Silvia Franchini

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Pain Management

Tissue Engineering

Top Venues

ACS chemical neuroscience

Future medicinal chemistry

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia Sorbi, Silvia Belluti, Claudio Giacinto Atene, Federica Marocchi, Pasquale Linciano, Neena Roy, Elia Paradiso, Casarini Livio, Simone Ronsisvalle, Tommaso Zanocco-Marani, Livio Brasili, Luisa Lanfrancone, Carol Imbriano, Giulia Di Rocco, Silvia Franchini
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting. International journal of molecular sciences 24 (11) (2023)
Luca Pinzi, Nicolo Bisi, Claudia Sorbi, Silvia Franchini, Nicolò Tonali, Giulio Rastelli
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status. Molecules (Basel, Switzerland) 28 (11) (2023)
Simone Ronsisvalle, Federica Panarello, Angelo Spadaro, Silvia Franchini, Matteo Pappalardo, Salvatore Guccione, Livia Basile
Pharmacological properties and biochemical mechanisms of μ-opioid receptor ligands might be due to different binding poses: MD studies. Future medicinal chemistry 12 (22) (2020)
Pasquale Linciano, Claudia Sorbi, Antonella Comitato, Anna Lesniak, Magdalena Bujalska-Zadrożny, Agata Pawłowska, Anna Bielenica, Jolanta Orzelska-Górka, Ewa Kędzierska, Grażyna Biała, Simone Ronsisvalle, Silvia Limoncella, Livio Casarini, Elena Cichero, Paola Fossa, Grzegorz Satała, Andrzej J Bojarski, Livio Brasili, Rita Bardoni, Silvia Franchini
Identification of a Potent and Selective 5-HT1A Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity. ACS chemical neuroscience 11 (24) (2020)
Fabio Del Bello, Dario Ambrosini, Alessandro Bonifazi, Amy Hauck Newman, Thomas M Keck, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Loredana Cappellacci, Antonio Cilia, Silvia Franchini, Wilma Quaglia
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia. ACS chemical neuroscience 10 (5) (2019)